Effectiveness and Safety of Adalimumab versus Leflunomide in Patients with Takayasu Arteritis - a Retrospective Cohort Study

被引：0
|
作者：
Filho, Faustino Peron [1 ]
de Souza Moreira, Andressa [2 ]
Janes, Anna Larissa [2 ]
de Souza, Alexandre Wagner [2 ]
机构：
[1] UNIFESP, EPM, Mogi Das Cruzes, SP, Brazil
[2] Univ Fed Sao Paulo, EPM, Sao Paulo, Brazil
来源：
ARTHRITIS & RHEUMATOLOGY | 2022年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1553
引用
收藏
页码：3076 / 3078
页数：3
相关论文
共 50 条
  • [1] Effectiveness and safety of adalimumab compared with leflunomide in patients with Takayasu arteritis: a retrospective cohort study
    Peron Filho, Faustino
    Moreira, Andressa de Souza
    Janes, Anna Larissa Faria
    de Souza, Alexandre W. S.
    [J]. RMD OPEN, 2024, 10 (01):
  • [2] Effectiveness and safety of methotrexate versus leflunomide in 12-month treatment for Takayasu arteritis
    Wu, Chunling
    Sun, Ying
    Cui, Xiaomeng
    Wu, Sifan
    Ma, Lili
    Chen, Huiyong
    Yan, Yan
    Ji, Zongfei
    Liu, Yun
    Lin, Jiang
    Lv, Peng
    Chen, Rongyi
    Yang, Pingting
    Jiang, Lindi
    [J]. THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2020, 11
  • [3] Efficacy and safety of leflunomide versus cyclophosphamide for initial-onset Takayasu arteritis: a prospective cohort study
    Sun Ying
    Cui Xiaomeng
    Dai Xiaomin
    Lin Jiang
    Lv Peng
    Ma Lili
    Chen Rongyi
    Ji Zongfei
    Chen Huiyong
    Jiang Lindi
    [J]. THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2020, 12
  • [4] EFFECTIVENESS AND SAFETY OF INTRAVENOUS VERSUS SUBCUTANEOUS TOCILIZUMAB IN TAKAYASU ARTERITIS: MULTICENTER RETROSPECTIVE STUDY
    Mekinian, A.
    Saadoun, D.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 639 - 639
  • [5] EFFICACY AND SAFETY OF TOFACITINIB VERSUS LEFLUNOMIDE TREATMENT IN TAKAYASU ARTERITIS: A PROSPECTIVE STUDY
    Wang, J.
    Dai, X.
    Ma, L.
    Wu, S.
    Jin, X.
    Ji, Z.
    Chen, H.
    Ma, L.
    Ding, Z.
    Jiang, L.
    Kong, X.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 686 - 687
  • [6] Efficacy and safety of tofacitinib versus leflunomide with glucocorticoids treatment in Takayasu arteritis: A prospective study
    Wang, Jinghua
    Dai, Xiaojuan
    Ma, Lingying
    Wu, Sifan
    Jin, Xuejuan
    Ji, Zongfei
    Chen, Huiyong
    Ma, Lili
    Ding, Zhenqi
    Jiang, Lindi
    Kong, Xiufang
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 2022, 55
  • [7] Effectiveness and safety of leflunomide compared with cyclophosphamide as induction therapy in Takayasu's arteritis: an observational study
    Dai, Xiaomin
    Cui, Xiaomeng
    Sun, Ying
    Ma, Lili
    Jiang, Lindi
    [J]. THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2020, 11
  • [8] Comment on: Treatment efficacy and safety of adalimumab versus tocilizumab in patients with active and severe Takayasu arteritis
    Misra, Durga Prasanna
    [J]. RHEUMATOLOGY, 2024, 63 (05): : e156 - e157
  • [9] Treatment efficacy and safety of adalimumab versus tocilizumab in patients with active and severe Takayasu arteritis: an open-label study
    Wang, Jinghua
    Kong, Xiufang
    Ma, Lili
    Ding, Zhenqi
    Chen, Huiyong
    Chen, Rongyi
    Jin, Xuejuan
    Chen, Caizhong
    Lin, Jiang
    Jiang, Lindi
    [J]. RHEUMATOLOGY, 2023, : 1359 - 1367
  • [10] CHARACTERISTICS OF PATIENTS WITH GIANT CELL ARTERITIS AND TAKAYASU ARTERITIS IN A NATIONWIDE, RETROSPECTIVE COHORT STUDY IN JAPAN
    Sugihara, Takahiko
    Hasegawa, Hitoshi
    Uchida, Haruhito
    Yoshifuji, Hajime
    Nakaoka, Yoshikazu
    Watanabe, Yoshiko
    Tanemoto, Kazuo
    Amiya, Eisuke
    Konishi, Masanori
    Arimura, Yoshihiro
    Isobe, Mitsuaki
    [J]. RHEUMATOLOGY, 2017, 56 : 52 - 52
12345